{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T16:00:22Z","timestamp":1778428822669,"version":"3.51.4"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T00:00:00Z","timestamp":1756339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2019\/15619-2, 2020\/08271-7, 2023\/02690-6, 2019\/19635-2, 2021\/03418-2, 2023\/03195-9, 23\/11322-0"],"award-info":[{"award-number":["2019\/15619-2, 2020\/08271-7, 2023\/02690-6, 2019\/19635-2, 2021\/03418-2, 2023\/03195-9, 23\/11322-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2008\/57889-1"],"award-info":[{"award-number":["2008\/57889-1"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Funda\u00e7\u00e3o Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"crossref","award":["88887.951013\/2024-00"],"award-info":[{"award-number":["88887.951013\/2024-00"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["573799\/2008-3"],"award-info":[{"award-number":["573799\/2008-3"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["88887.900865\/2023-00"],"award-info":[{"award-number":["88887.900865\/2023-00"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-15927-4","type":"journal-article","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T03:59:14Z","timestamp":1756353554000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The antitumor effect of tlr4 inhibition in head and neck cancer cell lines"],"prefix":"10.1038","volume":"15","author":[{"given":"Nat\u00e1lia Meneses","family":"Ara\u00fajo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna Barbosa","family":"Chanes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayo Alexandre Souza","family":"da Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ileana Gabriela Sanchez","family":"de Rubio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa Lina","family":"Villa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo Esaki","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirian Galliote","family":"Morale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,28]]},"reference":[{"key":"15927_CR1","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/B978-1-4377-1604-7.00196-2","volume":"1","author":"LQM Chow","year":"2012","unstructured":"Chow, L. Q. M. Head and neck cancer. Goldman\u2019s Cecil Med. Twenty Fourth Ed. 1, 1257\u20131264. https:\/\/doi.org\/10.1016\/B978-1-4377-1604-7.00196-2 (2012).","journal-title":"Goldman\u2019s Cecil Med. Twenty Fourth Ed."},{"key":"15927_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/nyas.12613","volume":"1333","author":"X Varelas","year":"2014","unstructured":"Varelas, X. & Kukuruzinska, M. A. Head and neck cancer: from research to therapy and cure. Ann. N Y Acad. Sci. 1333, 1\u201332. https:\/\/doi.org\/10.1111\/nyas.12613 (2014).","journal-title":"Ann. N Y Acad. Sci."},{"key":"15927_CR3","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.anl.2023.08.006","volume":"51","author":"T Kumai","year":"2024","unstructured":"Kumai, T. et al. Translational research in head and neck cancer: molecular and immunological updates. Auris Nasus Larynx. 51, 391\u2013400. https:\/\/doi.org\/10.1016\/j.anl.2023.08.006 (2024).","journal-title":"Auris Nasus Larynx"},{"key":"15927_CR4","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/s41415-022-5166-x","volume":"233","author":"M Gormley","year":"2022","unstructured":"Gormley, M., Creaney, G., Schache, A., Ingarfield, K. & Conway, D. I. Reviewing the epidemiology of head and neck cancer: definitions, trends and risk factors. Br. Dent. J. 233, 780\u2013786. https:\/\/doi.org\/10.1038\/s41415-022-5166-x (2022).","journal-title":"Br. Dent. J."},{"key":"15927_CR5","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s10555-017-9690-0","volume":"36","author":"D Kawakita","year":"2017","unstructured":"Kawakita, D. & Matsuo, K. Alcohol and head and neck cancer. Cancer Metastasis Rev. 36, 425\u2013434. https:\/\/doi.org\/10.1007\/s10555-017-9690-0 (2017).","journal-title":"Cancer Metastasis Rev."},{"key":"15927_CR6","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S1470-2045(10)70017-6.HPV-associated","volume":"176","author":"Shanthi","year":"2010","unstructured":"Shanthi et al. HPV-associated head and neck cancer: A virus-related cancer Epidemic \u2013 A review of epidemiology, biology, virus detection and issues in management. Lancet Oncol. 176, 139\u2013148. https:\/\/doi.org\/10.1016\/S1470-2045(10)70017-6.HPV-associated (2010).","journal-title":"Lancet Oncol."},{"key":"15927_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.mrrev.2016.07.002","volume":"772","author":"J Doorbar","year":"2017","unstructured":"Doorbar, J., Egawa, N., Griffin, H., Kranjec, C. & Murakami, I. Human papillomavirus molecular biology and disease association. Mutat. Res. - Rev. Mutat. Res. 772, 3\u201312. https:\/\/doi.org\/10.1016\/j.mrrev.2016.07.002 (2017).","journal-title":"Mutat. Res. - Rev. Mutat. Res."},{"key":"15927_CR8","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1089\/cbr.2017.2363","volume":"34","author":"LX Dai","year":"2019","unstructured":"Dai, L. X. et al. Adenovirus-Mediated CRM197 sensitizes human glioma cells to gemcitabine by the mitochondrial pathway. Cancer Biother Radiopharm. 34, 171\u2013180. https:\/\/doi.org\/10.1089\/cbr.2017.2363 (2019).","journal-title":"Cancer Biother Radiopharm"},{"key":"15927_CR9","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/s41416-024-02655-1","volume":"131","author":"H Tabatabaeian","year":"2024","unstructured":"Tabatabaeian, H., Bai, Y., Huang, R., Chaurasia, A. & Darido, C. Navigating therapeutic strategies: HPV classification in head and neck cancer. Br. J. Cancer. 131, 220\u2013230. https:\/\/doi.org\/10.1038\/s41416-024-02655-1 (2024).","journal-title":"Br. J. Cancer"},{"key":"15927_CR10","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41571-022-00603-7","volume":"19","author":"M Lechner","year":"2022","unstructured":"Lechner, M., Liu, J., Masterson, L. & Fenton, T. R. HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management. Nat. Rev. Clin. Oncol. 19, 306\u2013327. https:\/\/doi.org\/10.1038\/s41571-022-00603-7 (2022).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"15927_CR11","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1002\/jcb.25592","volume":"117","author":"G Zhou","year":"2016","unstructured":"Zhou, G., Liu, Z. & Myers, J. N. TP53 mutations in head and neck squamous cell carcinoma and their impact on disease progression and treatment response. J. Cell. Biochem. 117, 2682\u20132692. https:\/\/doi.org\/10.1002\/jcb.25592 (2016).","journal-title":"J. Cell. Biochem."},{"key":"15927_CR12","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nrc.2018.11","volume":"18","author":"CR Leemans","year":"2018","unstructured":"Leemans, C. R., Snijders, P. J. F. & Brakenhoff, R. H. The molecular landscape of head and neck cancer. Nat. Rev. Cancer. 18, 269\u2013282. https:\/\/doi.org\/10.1038\/nrc.2018.11 (2018).","journal-title":"Nat. Rev. Cancer"},{"key":"15927_CR13","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1002\/humu.22552","volume":"35","author":"B Leroy","year":"2014","unstructured":"Leroy, B., Anderson, M. & Soussi, T. TP53 mutations in human cancer: database reassessment and prospects for the next decade. Hum. Mutat. 35, 672\u2013688. https:\/\/doi.org\/10.1002\/humu.22552 (2014).","journal-title":"Hum. Mutat."},{"key":"15927_CR14","doi-asserted-by":"publisher","first-page":"23780","DOI":"10.18632\/oncotarget.25267","volume":"9","author":"FM Simabuco","year":"2018","unstructured":"Simabuco, F. M. et al. p53 and metabolism: from mechanism to therapeutics. Oncotarget 9, 23780\u201323823. https:\/\/doi.org\/10.18632\/oncotarget.25267 (2018).","journal-title":"Oncotarget"},{"key":"15927_CR15","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1242\/jcs.064501","volume":"123","author":"CA Brady","year":"2010","unstructured":"Brady, C. A. & Attardi, L. D. P53 at a glance. J. Cell. Sci. 123, 2527\u20132532. https:\/\/doi.org\/10.1242\/jcs.064501 (2010).","journal-title":"J. Cell. Sci."},{"key":"15927_CR16","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1200\/JCO.2000.18.2.385","volume":"18","author":"S Temam","year":"2000","unstructured":"Temam, S. et al. p53 gene status as a predictor of tumor response to induction chemotherapy of patients with locoregionally advanced squamous cell carcinomas of the head and neck. J. Clin. Oncol. 18, 385\u2013394 (2000).","journal-title":"J. Clin. Oncol."},{"key":"15927_CR17","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"15927_CR18","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1016\/j.hoc.2021.05.009","volume":"35","author":"H Shaikh","year":"2021","unstructured":"Shaikh, H., Karivedu, V. & Wise-Draper, T. M. Managing recurrent metastatic head and neck cancer. Hematol. Oncol. Clin. North. Am. 35, 1009\u20131020. https:\/\/doi.org\/10.1016\/j.hoc.2021.05.009 (2021).","journal-title":"Hematol. Oncol. Clin. North. Am."},{"key":"15927_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers13020338","volume":"13","author":"J Muzaffar","year":"2021","unstructured":"Muzaffar, J., Bari, S., Kirtane, K. & Chung, C. H. Recent advances and future directions in clinical management of head and neck squamous cell carcinoma. Cancers (Basel). 13, 1\u201316. https:\/\/doi.org\/10.3390\/cancers13020338 (2021).","journal-title":"Cancers (Basel)"},{"key":"15927_CR20","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1007\/s12094-020-02533-1","volume":"23","author":"R Mesia","year":"2021","unstructured":"Mesia, R. et al. SEOM clinical guidelines for the treatment of head and neck cancer (2020). Clin. Transl Oncol. 23, 913\u2013921. https:\/\/doi.org\/10.1007\/s12094-020-02533-1 (2021).","journal-title":"Clin. Transl Oncol."},{"key":"15927_CR21","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","volume":"740","author":"S Dasari","year":"2014","unstructured":"Dasari, S. & Bernard Tchounwou, P. Cisplatin in cancer therapy: molecular mechanisms of action. Eur. J. Pharmacol. 740, 364\u2013378. https:\/\/doi.org\/10.1016\/j.ejphar.2014.07.025 (2014).","journal-title":"Eur. J. Pharmacol."},{"key":"15927_CR22","doi-asserted-by":"publisher","unstructured":"Li, Q., Tie, Y., Alu, A., Ma, X. & Shi, H. Targeted therapy for head and neck cancer: signaling pathways and clinical studies. Signal. Transduct. Target. Ther. 8 https:\/\/doi.org\/10.1038\/s41392-022-01297-0 (2023).","DOI":"10.1038\/s41392-022-01297-0"},{"key":"15927_CR23","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s11864-023-01051-w","volume":"24","author":"SS Kim","year":"2023","unstructured":"Kim, S. S., Liu, H. C. & Mell, L. K. Treatment considerations for patients with locoregionally advanced head and neck cancer with a contraindication to cisplatin. Curr. Treat. Options Oncol. 24, 147\u2013161. https:\/\/doi.org\/10.1007\/s11864-023-01051-w (2023).","journal-title":"Curr. Treat. Options Oncol."},{"key":"15927_CR24","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.clon.2016.03.004","volume":"28","author":"R Simcock","year":"2016","unstructured":"Simcock, R. & Simo, R. Follow-up and survivorship in head and neck cancer. Clin. Oncol. 28, 451\u2013458. https:\/\/doi.org\/10.1016\/j.clon.2016.03.004 (2016).","journal-title":"Clin. Oncol."},{"key":"15927_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers12020297","volume":"12","author":"N Javaid","year":"2020","unstructured":"Javaid, N. & Choi, S. Toll-like receptors from the perspective of cancer treatment. Cancers (Basel). 12, 1\u201333. https:\/\/doi.org\/10.3390\/cancers12020297 (2020).","journal-title":"Cancers (Basel)"},{"key":"15927_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21197255","volume":"21","author":"S Hasnat","year":"2020","unstructured":"Hasnat, S., Hujanen, R., Nwaru, B. I., Salo, T. & Salem, A. The prognostic value of toll-like receptors in head and neck squamous cell carcinoma: A systematic review and meta-analysis. Int. J. Mol. Sci. 21, 1\u201319. https:\/\/doi.org\/10.3390\/ijms21197255 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"15927_CR27","doi-asserted-by":"publisher","unstructured":"Javaid, N., Yasmeen, F. & Choi, S. Toll-like receptors and relevant emerging therapeutics with reference to delivery methods. Pharmaceutics 11 https:\/\/doi.org\/10.3390\/pharmaceutics11090441 (2019).","DOI":"10.3390\/pharmaceutics11090441"},{"key":"15927_CR28","doi-asserted-by":"publisher","first-page":"e794","DOI":"10.1038\/cddis.2013.334","volume":"4","author":"X Yuan","year":"2013","unstructured":"Yuan, X. et al. Activation of TLR4 signaling promotes gastric cancer progression by inducing mitochondrial ROS production. Cell. Death Dis. 4, e794\u2013e794. https:\/\/doi.org\/10.1038\/cddis.2013.334 (2013).","journal-title":"Cell. Death Dis."},{"key":"15927_CR29","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1158\/0008-5472.CAN-10-1993","volume":"71","author":"Z Cai","year":"2011","unstructured":"Cai, Z. et al. Activation of toll-like receptor 5 on breast cancer cells by Flagellin suppresses cell proliferation and tumor growth. Cancer Res. 71, 2466\u20132475. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-1993 (2011).","journal-title":"Cancer Res."},{"key":"15927_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-018-4155-6","volume":"18","author":"R Sootichote","year":"2018","unstructured":"Sootichote, R. et al. Compound A attenuates toll-like receptor 4-mediated Paclitaxel resistance in breast cancer and melanoma through suppression of IL-8. BMC Cancer. 18, 1\u201312. https:\/\/doi.org\/10.1186\/s12885-018-4155-6 (2018).","journal-title":"BMC Cancer"},{"key":"15927_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0197327","volume":"13","author":"I Messaritakis","year":"2018","unstructured":"Messaritakis, I. et al. Evaluation of the detection of Toll-like receptors (TLRs) in cancer development and progression in patients with colorectal cancer. PLoS One. 13, 1\u201314. https:\/\/doi.org\/10.1371\/journal.pone.0197327 (2018).","journal-title":"PLoS One"},{"key":"15927_CR32","doi-asserted-by":"publisher","first-page":"703","DOI":"10.21873\/anticanres.13166","volume":"39","author":"Y Kusuhara","year":"2019","unstructured":"Kusuhara, Y. et al. Low expression of toll-like receptor 4 is associated with poor prognosis in bladder cancer. Anticancer Res. 39, 703\u2013711. https:\/\/doi.org\/10.21873\/anticanres.13166 (2019).","journal-title":"Anticancer Res."},{"key":"15927_CR33","doi-asserted-by":"publisher","first-page":"608","DOI":"10.7150\/ijms.8428","volume":"11","author":"Y Zhang","year":"2014","unstructured":"Zhang, Y. et al. The expression of toll-like receptor 8 and its relationship with VEGF and Bcl-2 in cervical cancer. Int. J. Med. Sci. 11, 608\u2013613. https:\/\/doi.org\/10.7150\/ijms.8428 (2014).","journal-title":"Int. J. Med. Sci."},{"key":"15927_CR34","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.intimp.2007.05.016","volume":"7","author":"K Chen","year":"2007","unstructured":"Chen, K. et al. Toll-like receptors in inflammation, infection and cancer. Int. Immunopharmacol. 7, 1271\u20131285. https:\/\/doi.org\/10.1016\/j.intimp.2007.05.016 (2007).","journal-title":"Int. Immunopharmacol."},{"key":"15927_CR35","doi-asserted-by":"publisher","first-page":"515","DOI":"10.17219\/acem\/87012","volume":"28","author":"D Diakowska","year":"2019","unstructured":"Diakowska, D., Nienartowicz, M., Grabowski, K., Rosi\u0144czuk, J. & Krzystek-Korpacka, M. Toll-like receptors TLR-2, TLR-4, TLR-7, and TLR-9 in tumor tissue and serum of the patients with esophageal squamous cell carcinoma and gastro-esophageal junction cancer. Adv. Clin. Exp. Med. 28, 515\u2013522. https:\/\/doi.org\/10.17219\/acem\/87012 (2019).","journal-title":"Adv. Clin. Exp. Med."},{"key":"15927_CR36","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.imbio.2016.06.009","volume":"222","author":"M Dajon","year":"2017","unstructured":"Dajon, M., Iribarren, K. & Cremer, I. Toll-like receptor stimulation in cancer: A pro- and anti-tumor double-edged sword. Immunobiology 222, 89\u2013100. https:\/\/doi.org\/10.1016\/j.imbio.2016.06.009 (2017).","journal-title":"Immunobiology"},{"key":"15927_CR37","doi-asserted-by":"publisher","first-page":"E3216","DOI":"10.1073\/pnas.1420811112","volume":"112","author":"S Haricharan","year":"2015","unstructured":"Haricharan, S. & Brown, P. TLR4 has a TP53-dependent dual role in regulating breast cancer cell growth. Proc. Natl. Acad. Sci. U S A. 112, E3216\u2013E3225. https:\/\/doi.org\/10.1073\/pnas.1420811112 (2015).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"15927_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-022-09980-6","volume":"12","author":"MG Morale","year":"2022","unstructured":"Morale, M. G., Tamura, R. E., Cintra, R., Ara\u00fajo, N. M. & Villa, L. L. TLR4 and SARM1 modulate survival and chemoresistance in an HPV-positive cervical cancer cell line. Sci. Rep. 12, 1\u201312. https:\/\/doi.org\/10.1038\/s41598-022-09980-6 (2022).","journal-title":"Sci. Rep."},{"key":"15927_CR39","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1111\/jop.12285","volume":"44","author":"Z He","year":"2015","unstructured":"He, Z. et al. Lipopolysaccharide enhances OSCC migration by promoting epithelial-mesenchymal transition. J. Oral Pathol. Med. 44, 685\u2013692. https:\/\/doi.org\/10.1111\/jop.12285 (2015).","journal-title":"J. Oral Pathol. Med."},{"key":"15927_CR40","first-page":"454","volume":"10","author":"H Ju","year":"2020","unstructured":"Ju, H. et al. tlr4 activation leads to antiegfr. Ther. Resist. HNSCC. 10, 454\u2013472 (2020).","journal-title":"Therapy Resist. HNSCC"},{"key":"15927_CR41","doi-asserted-by":"publisher","unstructured":"Yokota, T. et al. How should we approach locally advanced squamous cell carcinoma of head and neck cancer patients ineligible for standard Non-surgical treatment?? Curr Oncol Rep 2020;22. https:\/\/doi.org\/10.1007\/s11912-020-00984-x","DOI":"10.1007\/s11912-020-00984-x"},{"key":"15927_CR42","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11864-001-0012-x","volume":"2","author":"MS Kies","year":"2001","unstructured":"Kies, M. S., Bennett, C. L. & Vokes, E. E. Locally advanced head and neck cancer. Curr. Treat. Options Oncol. 2, 7\u201313. https:\/\/doi.org\/10.1007\/s11864-001-0012-x (2001).","journal-title":"Curr. Treat. Options Oncol."},{"key":"15927_CR43","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.critrevonc.2017.05.012","volume":"116","author":"B Paolo","year":"2017","unstructured":"Paolo, B. et al. The vicious circle of treatment-induced toxicities in locally advanced head and neck cancer and the impact on treatment intensity. Crit. Rev. Oncol. Hematol. 116, 82\u201388. https:\/\/doi.org\/10.1016\/j.critrevonc.2017.05.012 (2017).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"15927_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-4598-11-33","volume":"11","author":"Z Sun","year":"2012","unstructured":"Sun, Z., Luo, Q., Ye, D., Chen, W. & Chen, F. Role of toll-like receptor 4 on the immune escape of human oral squamous cell carcinoma and resistance of cisplatin-induced apoptosis. Mol. Cancer. 11, 1\u201312. https:\/\/doi.org\/10.1186\/1476-4598-11-33 (2012).","journal-title":"Mol. Cancer"},{"key":"15927_CR45","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.3892\/or.2014.3134","volume":"31","author":"G Ren","year":"2014","unstructured":"Ren, G. et al. Rapamycin inhibits Toll-like receptor 4-induced pro-oncogenic function in head and neck squamous cell carcinoma. Oncol. Rep. 31, 2804\u20132810. https:\/\/doi.org\/10.3892\/or.2014.3134 (2014).","journal-title":"Oncol. Rep."},{"key":"15927_CR46","doi-asserted-by":"publisher","unstructured":"Szczepanski, M. J. et al. Triggering of Toll-like receptor 4 expresed on human head and neck squamous cell carcinoma promotes tumor development and protects the tumor from immune attack 2013;69:3105\u20133113. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-3838.Triggering","DOI":"10.1158\/0008-5472.CAN-08-3838.Triggering"},{"key":"15927_CR47","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1002\/HED","volume":"36","author":"CJ Lin","year":"2014","unstructured":"Lin, C. J. et al. Head and neck squamous cell carcinoma cell lines: established models and rationale for selection. Head Neck. 36, 1391. https:\/\/doi.org\/10.1002\/HED (2014).","journal-title":"Head Neck"},{"key":"15927_CR48","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00280-019-03988-y","volume":"85","author":"B Kashani","year":"2020","unstructured":"Kashani, B. et al. Small molecule inhibitor of TLR4 inhibits ovarian cancer cell proliferation: new insight into the anticancer effect of TAK-242 (Resatorvid). Cancer Chemother. Pharmacol. 85, 47\u201359. https:\/\/doi.org\/10.1007\/s00280-019-03988-y (2020).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"15927_CR49","doi-asserted-by":"publisher","first-page":"114091","DOI":"10.1016\/j.yexcr.2024.114091","volume":"439","author":"Z Feng","year":"2024","unstructured":"Feng, Z. et al. TAK-242 inhibits glioblastoma invasion, migration, and proneural\u2013mesenchymal transition by inhibiting TLR4 signaling. Exp. Cell. Res. 439, 114091. https:\/\/doi.org\/10.1016\/j.yexcr.2024.114091 (2024).","journal-title":"Exp. Cell. Res."},{"key":"15927_CR50","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1002\/jcb.29397","volume":"121","author":"Z Zandi","year":"2020","unstructured":"Zandi, Z. et al. The anticancer effect of the TLR4 Inhibition using TAK-242 (resatorvid) either as a single agent or in combination with chemotherapy: A novel therapeutic potential for breast cancer. J. Cell. Biochem. 121, 1623\u20131634. https:\/\/doi.org\/10.1002\/jcb.29397 (2020).","journal-title":"J. Cell. Biochem."},{"key":"15927_CR51","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1007\/s12094-020-02353-3","volume":"22","author":"S Fan","year":"2020","unstructured":"Fan, S. et al. Targeting Toll-like receptor 4 with CLI-095 (TAK-242) enhances the antimetastatic effect of the Estrogen receptor antagonist fulvestrant on non-small cell lung cancer. Clin. Transl Oncol. 22, 2074\u20132086. https:\/\/doi.org\/10.1007\/s12094-020-02353-3 (2020).","journal-title":"Clin. Transl Oncol."},{"key":"15927_CR52","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/s41568-022-00450-9","volume":"22","author":"L Wang","year":"2022","unstructured":"Wang, L., Lankhorst, L. & Bernards, R. Exploiting senescence for the treatment of cancer. Nat. Rev. Cancer. 22, 340\u2013355. https:\/\/doi.org\/10.1038\/s41568-022-00450-9 (2022).","journal-title":"Nat. Rev. Cancer"},{"key":"15927_CR53","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/s41571-022-00668-4","volume":"19","author":"CA Schmitt","year":"2022","unstructured":"Schmitt, C. A., Wang, B. & Demaria, M. Senescence and cancer \u2014 role and therapeutic opportunities. Nat. Rev. Clin. Oncol. 19, 619\u2013636. https:\/\/doi.org\/10.1038\/s41571-022-00668-4 (2022).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"15927_CR54","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1002\/HED","volume":"36","author":"CT Allen","year":"2012","unstructured":"Allen, C. T., Law, J. H., Dunn, G. P. & Uppaluri, R. Emerging insights into head and neck cancer metastasis. Head Neck. 36, 1391. https:\/\/doi.org\/10.1002\/HED (2012).","journal-title":"Head Neck"},{"key":"15927_CR55","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s00405-020-06118-0","volume":"278","author":"MF van der Kamp","year":"2021","unstructured":"van der Kamp, M. F. et al. Predictors for distant metastasis in head and neck cancer, with emphasis on age. Eur. Arch. Oto-Rhino-Laryngology. 278, 181\u2013190. https:\/\/doi.org\/10.1007\/s00405-020-06118-0 (2021).","journal-title":"Eur. Arch. Oto-Rhino-Laryngology"},{"key":"15927_CR56","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1002\/HED","volume":"36","author":"D Fr\u00e9deric","year":"2016","unstructured":"Fr\u00e9deric, D. et al. Distant metastasis in head and neck cancer. Head Neck. 36, 1391. https:\/\/doi.org\/10.1002\/HED (2016).","journal-title":"Head Neck"},{"key":"15927_CR57","doi-asserted-by":"publisher","unstructured":"Tang, E. et al. Treatment strategy for distant synchronous metastatic head and neck squamous cell carcinoma. Curr. Oncol. Rep. 2019;21. https:\/\/doi.org\/10.1007\/s11912-019-0856-5","DOI":"10.1007\/s11912-019-0856-5"},{"key":"15927_CR58","doi-asserted-by":"publisher","unstructured":"Cirillo, N., Wu, C. & Prime, S. S. Heterogeneity of cancer stem cells in tumorigenesis, metastasis, and resistance to antineoplastic treatment of head and neck tumours. Cells https:\/\/doi.org\/10.3390\/cells10113068 (2021).","DOI":"10.3390\/cells10113068"},{"key":"15927_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-49771-0","volume":"9","author":"J Wang","year":"2019","unstructured":"Wang, J. et al. HPV-positive status associated with inflamed immune microenvironment and improved response to anti-PD-1 therapy in head and neck squamous cell carcinoma. Sci. Rep. 9, 1\u201310. https:\/\/doi.org\/10.1038\/s41598-019-49771-0 (2019).","journal-title":"Sci. Rep."},{"key":"15927_CR60","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1097\/CCO.0b013e32835b6386","volume":"25","author":"D Menendez","year":"2013","unstructured":"Menendez, D., Shatz, M. & Resnick, M. A. Interactions between the tumor suppressor p53 and immune responses. Curr. Opin. Oncol. 25, 85\u201392. https:\/\/doi.org\/10.1097\/CCO.0b013e32835b6386 (2013).","journal-title":"Curr. Opin. Oncol."},{"key":"15927_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21103452","volume":"21","author":"AD Agupitan","year":"2020","unstructured":"Agupitan, A. D. et al. P53: A guardian of immunity becomes its saboteur through mutation. Int. J. Mol. Sci. 21, 1\u201327. https:\/\/doi.org\/10.3390\/ijms21103452 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"15927_CR62","doi-asserted-by":"publisher","unstructured":"Menendez, D. et al. The toll-like receptor gene family is integrated into human DNA damage and p53 networks. PLoS Genet. 7. https:\/\/doi.org\/10.1371\/journal.pgen.1001360 (2011).","DOI":"10.1371\/journal.pgen.1001360"},{"key":"15927_CR63","doi-asserted-by":"publisher","first-page":"3949","DOI":"10.1158\/0008-5472.CAN-11-4134","volume":"72","author":"M Shatz","year":"2012","unstructured":"Shatz, M., Menendez, D. & Resnick, M. A. The human TLR innate immune gene family is differentially influenced by DNA stress and p53 status in cancer cells. Cancer Res. 72, 3949\u20133957. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-4134 (2012).","journal-title":"Cancer Res."},{"key":"15927_CR64","doi-asserted-by":"publisher","unstructured":"Kong, L. R. et al. Targeting codon 158 p53-mutant cancers via the induction of p53 acetylation. Nat. Commun.. https:\/\/doi.org\/10.1038\/s41467-020-15608-y (2020).","DOI":"10.1038\/s41467-020-15608-y"},{"key":"15927_CR65","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1002\/1878-0261.12851","volume":"14","author":"A Ahmed","year":"2020","unstructured":"Ahmed, A. & Tait, S. W. G. Targeting Immunogenic cell death in cancer. Mol. Oncol. 14, 2994\u20133006. https:\/\/doi.org\/10.1002\/1878-0261.12851 (2020).","journal-title":"Mol. Oncol."},{"key":"15927_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers13051069","volume":"13","author":"EL G\u00f6ttgens","year":"2021","unstructured":"G\u00f6ttgens, E. L., Ansems, M., Leenders, W. P. J., Bussink, J. & Span, P. N. Genotyping and characterization of Hpv status, hypoxia, and radiosensitivity in 22 head and neck cancer cell lines. Cancers (Basel). 13, 1\u201312. https:\/\/doi.org\/10.3390\/cancers13051069 (2021).","journal-title":"Cancers (Basel)"},{"key":"15927_CR67","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.oraloncology.2006.09.001","volume":"43","author":"JS White","year":"2007","unstructured":"White, J. S. et al. The influence of clinical and demographic risk factors on the establishment of head and neck squamous cell carcinoma cell lines. Oral Oncol. 43, 701\u2013712. https:\/\/doi.org\/10.1016\/j.oraloncology.2006.09.001 (2007).","journal-title":"Oral Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15927-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15927-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15927-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T19:51:04Z","timestamp":1757447464000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15927-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,28]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["15927"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-15927-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,28]]},"assertion":[{"value":"15 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The other authors declare that they have no potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31681"}}